HBI hears that the sale of UK-based private dental partnership network Dentex is underway, and catches up with a well-placed source to find out more about first-round bidders and pricing.
HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
Main Capital Partners, a European private equity group focused on investing into enterprise software companies, has bought a majority stake in Finnish telehealth provider VideoVisit. The company plans to expand internationally.
Ramsay Santé, the European branch of multinational hospital giant Ramsay Healthcare, has sealed the deal for its acquisition of listed Swedish specialty care provider GHP Specialty Care, having obtained 96.6% of its shares before the closing of the initial acceptance period on Friday, April 22.
As predicted by HBI earlier this year, fast-growing German and Swiss ophthalmology group Sanoptis has sold - but to an unexpected buyer. Owner Telemos Capital has signed an agreement to sell to family-backed investment holding company Groupe Bruxelles Lambert (GBL), the same group which has also just agreed to buy a majority stake in European imaging and cancer treatment provider Affidea.
Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
Last week we reported that French lab group Inovie is currently in the process of looking for a new majority shareholder. Could private equity fund Ardian be looking to sell its (minority) stake.
French lab group Inovie is looking for a new majority stakeholder off a €4bn+ enterprise value, HBI hears. Inovie is currently working with financial advisers to determine interest from potential buyers.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
